NCT02558348
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02558348 |
| Title | Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) |
| Acronym | AL3818 |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Advenchen Laboratories, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
CKB BOOST